Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year Update
- 19 January 2023
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 168 (6) , 1570-1575
Abstract
The North American Airway Collaborative (NoAAC) previously published a 3‐year multi‐institutional prospective cohort study showing variation in treatment effectiveness between 3 primary surgical techniques for idiopathic subglottic stenosis (iSGS). In this report, we update these findings to include 5 years of data evaluating treatment effectiveness. Patients in the NoAAC cohort were re‐enrolled for 2 additional years and followed using the prespecified published protocol. Consistent with prior data, prospective observation of 487 iSGS patients for 5 years showed treatment effectiveness differed by modality. Cricotracheal resection maintained the lowest rate of recurrent operation (5%), followed by endoscopic resection with adjuvant medical therapy (30%) and endoscopic dilation (50%). These data support the initial observations and continue to provide value to providers and patients navigating longitudinal decision‐making.Level of evidence: 2—prospective cohort study.Keywords
This publication has 5 references indexed in Scilit:
- Comparative Treatment Outcomes for Patients With Idiopathic Subglottic StenosisJAMA Otolaryngology–Head & Neck Surgery, 2020
- Treatment options in idiopathic subglottic stenosis: protocol for a prospective international multicentre pragmatic trialBMJ Open, 2018
- Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosisThe Laryngoscope, 2015
- Causes and consequences of adult laryngotracheal stenosisThe Laryngoscope, 2014
- Subglottic stenosis: A ten‐year review of treatment outcomesThe Laryngoscope, 2013